Hasuo Hideaki

ハスオヒデアキ | Hasuo Hideaki

Affiliation and department：
Job title： Professor
Research theme for competitive and other funds (11)：

2022 - 2025 がん患者の難治性神経障害性疼痛への標準的薬物療法に対する有効性評価の確立
2022 - 2024 進行がん患者の筋筋膜性疼痛に対するトリガーポイント注射の有効性についての探索的多施設共同オープンラベル無作為化割付比較試験
2021 - 2024 がん患者の不眠障害に対する完全在宅型心拍変動バイオフィードバックシステムの開発
2020 - 2022 QOL計測とハートフルネス実践による食体験共創システム
2019 - 2022 乳がん患者へのマインドフルネスストレス低減法による介入効果の検討

Show all

Papers (45)：

Yukie Saka-Kochi, Kenji Kanbara, Kohei Yoshida, Fumie Kato, Sadanobu Kawashima, Tetsuya Abe, Hideaki Hasuo. Stress Response Pattern of Heart Rate Variability in Patients with Functional Somatic Syndromes. Applied Psychophysiology and Biofeedback. 2023
Kohei Yoshida, Tetsuya Abe, Kenji Kanbara, Kento Ueda, Yukie Saka-Kouchi, Hideaki Hasuo. Patients with postprandial distress syndrome experience problems with their interoceptive perceptual function to the gastric region, but their heartbeat perception is normal: a case control study. BioPsychoSocial medicine. 2023. 17. 1. 35-35
Yoshinobu Matsuda, Hideaki Hasuo, Keiichi Narita, Hiromichi Matsuoka, Ryo Morita, Daisuke Kiuchi, Tomoo Ikari, Tetsuo Hori, Koya Okazaki, Kiyohiro Sakai, et al. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive & Palliative Care. 2022. bmjspcare-2021
松田能宣, 蓮尾英明, 成田慶一, 松岡弘道, 守田亮, 木内大佑, 猪狩智生, 堀哲雄, 岡崎航也, 酒井清裕, et al. がん患者の呼吸困難に関連する因子の相互作用および因果関係に関する横断研究 JORTC-PAL19. Palliative Care Research. 2022. 17. Suppl. S.182-S.182
Tatsuo Akechi, Yosuke Kubota, Yoichi Ohtake, Noriko Setou, Maiko Fujimori, Emi Takeuchi, Akiko Kurata, Masako Okamura, Hideaki Hasuo, Ryo Sakamoto, et al. Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer. Japanese journal of clinical oncology. 2022. 52. 6. 642-645

ｍore...

MISC (3)：

Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, Takashi Kawaguchi, Keisuke Ariyoshi, Shunsuke Oyamada, Eriko Satomi, Hiroto Ishiki, Hideaki Hasuo, Hiroko Sakuma, et al. Multi-centre, randomised, double-blind, placebo-controlled trial of additive duloxetine for cancer-related neuropathic pain refractory to opioids and gabapentinoids. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2018. 14. 161-162
Eriko Satomi, Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, Takashi Kawaguchi, Keisuke Ariyoshi, Shunsuke Oyamada, Hideaki Hasuo, Akihiro Tokoro, Toshiaki Shinomiya, et al. A multi-center, randomized, double-blinded, placebo-controlled trial of additive effect of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: JORTC-PAL08 (DIRECT study). JOURNAL OF CLINICAL ONCOLOGY. 2018. 36. 15
蓮尾英明, 田上恵太, 三浦智史, 松本禎久, 木下寛也. 事例紹介. 肺癌. 2014. 54. 5. 306-306

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page